elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27852097-2064E58D-8286-48E6-A32B-82C6F9CAB3F0
Q27852097-2064E58D-8286-48E6-A32B-82C6F9CAB3F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-2064E58D-8286-48E6-A32B-82C6F9CAB3F0
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
P2093
Q27852097-2064E58D-8286-48E6-A32B-82C6F9CAB3F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-2064E58D-8286-48E6-A32B-82C6F9CAB3F0
rank
NormalRank
type
BestRank
Statement
P1545
19
http://www.w3.org/2001/XMLSchema#string
P2093
Prabhu Rajagopalan
http://www.w3.org/2001/XMLSchema#string